MarketPeel
Insider Trading Intelligence
PS

Philippe Sauvage

NUVB
CHIEF FINANCIAL OFFICER · NUVATION BIO INC. · CIK 0002039891
FILING MIX · LIFETIME75%/25%
BUYS
6
SELLS
2
TOTAL VALUE
$403.0K
COMPANIES
1
ACTIVE SINCE
Oct 2024
HOLDINGS NOW
60,341
AVG SELL PX
$6.01
TRADE KIND
SHOWING 8 / 8
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizons · 2 pending
Forward-return performance of every backtestable P/S trade by Philippe Sauvage, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+100.00%+14.51%+0.56%+13.95%+13.95%
14d2+100.00%+9.14%+2.94%+6.20%+6.20%
30d2+100.00%+25.44%+4.34%+21.10%+21.10%
60d2+100.00%+54.33%+7.22%+47.11%+47.11%
90d2+100.00%+76.78%+10.13%+66.65%+66.65%
180d2+100.00%+375.44%+13.52%+361.92%+361.92%
1y2+100.00%+176.32%+25.41%+150.91%+150.91%
2y2(2 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
NUVB · 60,341 shares · as of Jun 23, 2026
0187,500375,000562,500750,00020252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2024
2025
2025
2025
2025
2026
2026
FLOW · 6 buys / 2 sellsCOVERAGE · 7 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
NUVB
NUVATION BIO INC.
PURCHASE
Chief Financial Officer
47,668$2.17$103.4K60,341Jun 23, 2026Jun 24, 2026View →
NUVB
NUVATION BIO INC.
SALE
Chief Financial Officer
47,668702,332Jun 23, 2026Jun 24, 2026View →
NUVB
NUVATION BIO INC.
SALE10b5-1
10b5-1 plan
47,668$6.01$286.4K12,673Jun 23, 2026Jun 24, 2026View →
NUVB
NUVATION BIO INC.
PURCHASEGRANT
Stock grant
748,130748,130Feb 27, 2026Mar 3, 2026View →
NUVB
NUVATION BIO INC.
PURCHASE
Chief Financial Officer
4,000$1.79$7.2K9,902Jun 17, 2025Jun 18, 2025View →
NUVB
NUVATION BIO INC.
PURCHASE
Chief Financial Officer
3,300$1.84$6.1K5,902Jun 16, 2025Jun 18, 2025View →
NUVB
NUVATION BIO INC.
PURCHASEGRANT
Stock grant
500,000500,000Feb 28, 2025Mar 4, 2025View →
NUVB
NUVATION BIO INC.
PURCHASEGRANT
Stock grant
750,000750,000Oct 7, 2024Oct 9, 2024View →
Other insiders · NUVB
Loading peer insiders…
About this filer
CIK 0002039891
ROLE
Chief Financial Officer
PRIMARY
NUVB
COMPANIES
1
ACTIVE SINCE
Oct 2024
MARKETPEEL · /INSIDER/0002039891DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback